Apr 19, 2022Tessera Therapeutics Announces Over $300M Series C Financing to Advance its GENE WRITING PlatformSOMERVILLE, Mass.--(BUSINESS WIRE)--Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known...
Apr 12, 2022Ansa Biotechnologies Closes Oversubscribed $68 Million Series A FinancingAnsa’s next-generation enzymatic DNA synthesis technology will dramatically accelerate innovation across every industry enabled by...